Global Research and Evidence Lab 13 August 2024 PBF Energy Inc Adjusting Estimates and Price Target Adjusting estimates We are adjusting our estimates to reflect weaker cracks environment. We lower 2024 to reflect weaker earnings vs. our expectations. West Coast cracks are trending below expectations (despite closure of Rodeo) and this is driving negative revisions. We lower 2024 EPS to $1.06 from $4.04. We lower 2025 EPS to $3.26 from $5.52. Call takeaways ● Turnaround in both East Coast and Mid-Con lasted ...

Global Research and Evidence Lab 13 August 2024 First Read Synthomer PLC 1H24 results - 5% EBITDA miss, with outlook unchanged Q: How did the results compare vs expectations? A: Synthomer reported 1H24 adjusted EBITDA of £76m, up 4% y/y but 5% below Bloomberg consensus at £80m (UBSe at £77m). Sales came in at £1,051m, up 0.4% y/y and 1% above consensus of £1,041m, driven by price/mix down 7%, volumes up 11% and an FX headwind of 3% y/y. 1H24 adjusted EPS was 1.3p, compared to a loss per share of 8.0p in 1H2 ...

ab 13 August 2024 Global Research and Evidence Lab First Read Netwealth Group Limited UBS Snapshot: FY24 Result ONE LINER Earnings and div miss due to revenue margins. FY25 guidance is for flows to remain strong but cost growth to accelerate. KEY NUMBERS (1) Reported NPAT $83.4m vs UBSe $88.1m (Cons $85.6m); (2) Total revenue +18.9% to $255.2m vs UBSe $260.4m (Cons $258.4m); (3) EBITDA $124.7m vs UBSe $129.8m (Cons. $127.2m); (4) Underlying EPS 33.8cps vs UBSe 36.1cps (Cons. 35.0cps); (5) Final DPS 14.0cps ...

First Read Challenger UBS SnapShot: FY24 Result ONE LINER Earnings and div beat due to improving core margins and lower costs. PCA multiple rises to top end of target range. Buy rating KEY NUMBERS (1) Normalised NPBT +17% to A$608m (UBSe & Cons $600m), $318 2H (vs $290m 1H). (2) Normalised NPAT $417m in-line with UBSe & Cons $417m. (3) Final DPS 13.5cps ff (UBSe 12.5cps, consensus 12.7c). (4) 1H24 Annuity sales -6% to $5.19bn (UBSe $5.14bn). RESULT HIGHLIGHTS (1) Life EBIT +17% to $634m vs consensus $619m, ...

First Read Temple & Webster Group UBS SnapShot: FY24 Results ONE LINER: EBITDA beat, sales inline, trading update +26% y/y OUTLOOK AND GUIDANCE: FY25 commenced strongly with revenue first 6wks up 26% year on year. FY25 will continue to include an additional 2-3% of revenue invested into brand marketing across brand and performance channels. FY25 EBITDA mgn inc marketing investment 1-3%. EBITDA margins to incrementally build from FY26 towards LT BAU EBITDA margin of +15%. Current $30m on-market buyback will ...

ab 13 August 2024 Global Research and Evidence Lab First Read Seek UBS SnapShot: 2H24 Result ONE LINER Top line delivered in 2H but higher D&A and interest drag on NPAT. FY25e outlook suggests yield stronger, and assuming worse than expected ANZ vols 2H24 KEY NUMBERS Rev $563m (UBSe $563m, VA cons $537m); EBITDA $230m (UBSe $235m, cons. $238m); Adjusted NPAT $64m (UBSe $74m, cons. $80m); Capex -$73m (UBSe $-88m, cons -$89m); Div 16cps (UBSe 15cps, cons. 16cps) 2H24 RESULT HIGHLIGHTS 1. ANZ Rev -7% y/y to $4 ...

ab 12 August 2024 Global Research and Evidence Lab India Economic Comment Headline CPI inflation softens on base effect Headline CPI inflation eases to 3.5% in July, core inflation at 3.4% Headline CPI inflation eased to a five-year low of 3.5% YoY in July (vs. 5.1%YoY in the previous month), largely due to base effect despite a pick-up in sequential momentum in food prices (largely seasonal) and hike in telecom tariffs by telcos (15bps contribution). This inflation print was lower than consensus expectatio ...

First Read Region Group UBS SnapShot: FY24 Result ONE LINER FY24 -2% below UBSe on lower NPI (prop. expenses), FY25 FFOpu guidance -3% vs. cons. KEY NUMBERS FFO $178.4m vs UBSe $181.3m; FFOpu 15.4c (-9% vs pcp) vs UBSe 15.6c (cons. 15.6c); 13.7c DPS (pre-announced). RESULT HIGHLIGHTS 1. Supermarkets MAT +3.0% (+4.2% Dec-23), DDS +1.1% (+2.1% Dec-23). Comp specialty MAT growth +1.4% (+2.5% Dec-23). Leasing spreads for renewals +5.2% (+4.4% Dec-23). New tenants leasing +1.6% (-0.3% Dec-23) as incentives are 9 ...

ab 13 August 2024 Global Research and Evidence Lab Equities Morning Expresso – Australasia Tuesday, 13 August 2024 Australasia Marcus Curley Analyst marcus.curley@ubs.com +64-9-913 4750 Today's Notes INDUSTRIALS Carsales.com.au - Good outlook into FY25e JB Hi-Fi - FY24 Result: JB Aust EBIT margin 'base' raised Aurizon - FY24 result: Capital flexibility preserved FINANCIALS Australian Banks - Capital returns are possibly mispriced RESOURCES Alcoa Corporation - Initiate coverage on AAI.AU Buy rated A$58/sh Be ...

ab 13 August 2024 Global Research and Evidence Lab First Read CSL FY24: Largely in line, but looking closely at Behring core gross margin ONE LINER Largely inline result except for a c.60-bps miss for Behring core gross margin, which we think will attract questions (at CC it looked in line). KEY NUMBERS 1. Revenue $14,800m +11% (+11% CC), in line with consensus 2. Underlying gross margin 54.1%, 65bps ahead of consensus 3. NPATA $2,907m +11% (+15% CC), -5% below consensus RESULTS HIGHLIGHTS 1. Behring revenu ...